Chemours: Solid Q2 And Legal Progress Are Bullish (Rating Upgrade)
Chemours is showing financial improvement, especially in Opteon refrigerants, despite industry headwinds and a recent dividend cut. The company's legal overhang is easing after a favorable New Jersey PFAS settlement, freeing up future cash flow and reducing uncertainty. Balance sheet leverage remains high, but improving free cash flow in the second half should reduce net debt and support the current dividend.
The Chemours Company (CC) Q2 2025 Earnings Call Transcript
The Chemours Company (NYSE:CC ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Brandon Ontjes - Vice President of Investor Relations Denise M. Dignam - President, CEO & Director Shane W.
Chemours (CC) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Chemours (CC) Tops Q2 Earnings and Revenue Estimates
Chemours (CC) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.38 per share a year ago.
Chemours: Refrigerants Make This Company A Buy Before Q2 2025 Report
Chemours is at a cyclical low, presenting a buying opportunity ahead of expected 2Q25 revenue growth. Despite legacy risks and sub-par credit, Chemours' leadership in low-impact refrigerants and proprietary titanium technology sets it apart from competitors. Current market and analyst sentiment underestimates Chemours' potential, with forecasts showing strong EPS and EBITDA growth through 2026-2027.
CC Sees Gains From Opteon Growth in Q2, Navigates Disruptions in TT
Chemours' second-quarter sales are expected to be at the high end of its guidance as TT disruptions get offset by Opteon demand boosts.
Chemours Joins DataVolt to Advance Liquid Cooling for AI Data Centers
The deal will enable CC to focus on improving data center efficiency by using two-phase direct-to-chip, two-phase immersion cooling and other new methods.
Chemours & Navin Fluorine Partner to Produce Liquid Cooling Product
CC partners with Navin Fluorine to facilitate the adoption of two-phase liquid cooling.
Chemours' Q1 Earnings Miss Estimates, Revenues Increase Y/Y
CC's first-quarter earnings miss estimates, but revenues beat the same on increased sales from Titanium Technologies and Thermal & Specialized Solutions.
The Chemours Company (CC) Q1 2025 Earnings Call Transcript
The Chemours Company (NYSE:CC ) Q1 2025 Results Conference Call May 7, 2025 8:00 AM ET Company Participants Brandon Ontjes - VP, Investor Relations Denise Dignam - President & Chief Executive Officer Shane Hostetter - Chief Financial Officer Conference Call Participants John McNulty - BMO John Roberts - Mizuho Pete Osterland - Truist Laurence Alexander - Research Analyst Arun Viswanathan - RBC Capital Markets Josh Spector - UBS Duffy Fischer - Goldman Sachs Mike Leithead - Barclays Operator Good morning. My name is Michelle, and I will be your conference operator today.
Chemours: Dividend Cut May Signal A Bottom Is Near
Chemours has faced significant challenges, including weak demand, excess supply, and poor earnings, leading to a 50% drop in stock value and a 9% after-hours plunge. Despite weak performance, Chemours is nearing a potential buy point due to its free cash flow generation and strategic dividend cut to safeguard its balance sheet. CC expects sequential sales growth and a 40-45% increase in adjusted EBITDA, but the outlook remains cautious due to economic uncertainties and tariffs.
Chemours (CC) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
